UnknownNot Applicable

Normal Quantitative EEG (qEEG) Dataset

United States80 participantsStarted 2014-03

Plain-language summary

In this study, the investigators will collect EEG data in normal, healthy volunteers without a history of prior brain injury. This data will be analyzed by computer (quantitative, or qEEG) and stored in a normative database so that, in the future, the investigators can better understand and characterize the brain damage that can result from carbon monoxide (CO) poisoning and other types of brain injury.

Who can participate

Age range

18 Years – 55 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men and women, from 18 to 55 years old at the time of study enrollment. Women who are greater than 6 weeks post-partum, who are breastfeeding are allowed to participate if they are able to finish the electroencephalography (EEG) without interruption. * Able to speak and read English as their primary language. * Agrees to, and appears able to, participate in all outcome assessments. * Demonstrates the ability to offer informed consent and signs the study informed consent document. Exclusion Criteria: * Vulnerable populations including, prisoners, pregnant women, and minors. * Women who are less than 6 weeks post-partum. * Unwilling or unable to participate in planned study visits. * Any past history of brain injury due to trauma, surgery, hypoxia, infection, inflammation, toxicity (e. g., carbon monoxide poisoning), or cerebrovascular etiology. * Individuals with a diagnosis of, or a persistent history of, or symptoms of a neurological disorder (e.g., tinnitus, vertigo, chronic fatigue, numbness, tingling, chronic migraine, fibromyalgia, multiple sclerosis). * Currently undergoing therapy for affective disorders, behavioral disorders, or psychological disorders. * Diagnosis of post-traumatic stress disorder or sub-clinical post-traumatic stress symptoms. * Diagnosis of diabetes mellitus, type 1 and type 2. * Current complaints of brain injury symptoms such as cognitive or affective problems. * Known neuroimaging abnormalities. * Participants taking dai…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Electroencephalography Completion Questionnaire (Y/N)

Timeframe: Baseline

Trial details

NCT IDNCT02375126

SponsorIntermountain Health Care, Inc.

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12

Contact for this trial

Lindell K Weaver, MD

801-408-3623 lindell.weaver@imail.org

View on ClinicalTrials.gov More Carbon Monoxide Poisoning trials